Download
1 / 3
30 likes | 37 Views
As India is the biggest consumer of antibiotics in the world, causing lakhs of deaths every year. Fighting this, it has joined hands with the Global Antimicrobial Resistance Research and Development Hub on 12th September 2019
E N D
India is among the countries with the highest amount of bacterial diseases in the world, and is also the largest consumer of antibiotics in the world, wherein the consumption has increased by 103% from 2000 to 2015! This is the highest increase in low and middle income countries. As per the reports of the World Health Organization, more than 7,00,000 people die from microbial infections every year! And, this number is only set to rise above the mark of 10 million deaths per year in the coming years, if no proper action is taken. Microbial infection has thus become a cause of worry not only in India, but also many other developing nations where the burden of infectious disease is high, and the healthcare spending is low. India Joins Global Antimicrobial Resistance Research And Development Hub With such high number of bacterial disease patients, India gives a great platform for relevant researches. And, this is why the country has become a part of the Global
Antimicrobial Resistance Research and Development Hub on 12 September 2019. This development hub was launched during the 71st session of the World Health Assembly in 2018, aiming to help countries decide the allocation of resources for research and development on antimicrobial resistance, by identifying gaps and overlaps. The hub will also promote coordination among governments in the fight against antimicrobial resistance. What is the Hub? This hub is headquartered in Germany, whose membership is open to countries and philanthropic foundations. This global partnership includes a total number of 16 countries, the European Commision, four international organizations, and two philantrophic foundations. And now, with India being a member, the hub now represents more than half the world’s population! What is the role of this Hub? The developmental hub has a provisional work plan from 2018 to 2021 to propose to develop a dynamic dashboard, establish operational activities and procedures, and engage experts in ad-hoc Expert Advisory Groups to understand the range of R&D incentives and gaps in the incentive toolbox. With this work plan, a global network of researchers ReAct, pointed out six issues in September 2018. They not only wanted to reduce the threat of antibiotics resistance, but also wanted more clarity in the hub’s role in taking action and influencing decision-making, needing to look beyond antibiotic R&D pipeline, and avoiding distorting the prioritization of investments. What does Renu Swarup have to say? Renu Swarup, secretary department of biotechnology, Union Ministry of Science & Technology, in a press release, said, “We all have a role to play to protect the efficacy of antimicrobial agents and to support the efforts of the different sectors at national, regional and global levels. Working together, we can address this threat and change the trajectory of health for humanity. By partnering, with the Global AMR R&D Hub, we look forward to working with all partners to leverage their existing capabilities, resources and collectively focus on new R&D intervention to address drug resistant infections.”
As India goes global, it brings more and more opportunities for researchers to get amazing job opportunities. But for this, one needs the best clinical research training in Bangalore from a reputed institute like Avigna Clinical Research Institute.
